Figure 2

Malaria antigen prevalence by Nigerian state among 0–59-month-olds from 2018 NAIIS compared to the 2018 DHS. (a) RDT prevalence by DHS compared with HRP2 antigen prevalence from NAIIS samples. (b) Microscopy prevalence by DHS compared with HRP2 antigen prevalence from NAIIS samples.